PURCHASE, NY – Maypro’s L-92™ probiotic ingredient has won the 2016 NutrAward, making Maypro a four time NutrAward winner. In past years, Maypro’s AHCC®, Oligonol® and PQQ have all received this prestigious industry recognition.
The NutrAward is the industry’s longest running award that recognizes outstanding products, such as Maypro’s L-92™, based on scientific merit, safety and efficacy, market potential, innovation and their ability to increase market credibility. The judging panel is made up of industry experts, scientists, and nutritionists. Registered attendees for Natural Products Expo West were also given the opportunity to vote for their favorite ingredient and finished product.
Protected by patents, L-92™ is supported by 4 published double-blind placebo-controlled human clinical studies in both children and adults. With promising applications as a medical food, L-92™ has been shown in human clinical studies to help with the dietary management of patients with psoriasis, allergic rhinitis, and cedar pollinosis. These studies have shown that L-92™ could soothe and calm irritated skin, reduce redness and swelling, as well as reduce seasonal discomforts.*
To illustrate the effect of L-92™’s clinical efficiency, a study published in the International Archives of Allergy and Immunology observed 49 patients with atopic dermatitis, ages 16 and over, who received 20.7 mg/day for a total of 8 weeks. The study found that L-92™ can be used as a food supplement to reduce the dose of steroidal anti-inflammatory ointments required for atopic treatment. L-92™ may contribute to the suppression of Th2-dominant inflammation.*
Manufactured from Lactobacillus acidophilus of human origin, L-92™ is leading the innovation in the field of "zombie probiotics” – intentionally heat-sterilized "dead" bacteria which have been found to down-regulate an overactive immune system more effectively than their "live" originals.
“This product has achieved great success in Japan, both in direct-to-consumer and mass market channels,” said Steve Yamada, Chairman of Maypro Group. “We expect L-92™ to do equally well in the US market with the support of our customers and our great manufacturing partner.”
"We are honored to have received this recognition for us and our close partner Asahi Calpis Wellness, which has invested significantly in rigorous clinical research and greatly supported our sales and marketing efforts," said Dan Lifton, President of Maypro's Proprietary & Branded Ingredients business.
Click HERE to watch the 2016 NutrAward acceptance speech given by Chairman and CEO of Maypro, Steve Yamada.
*These statements have not been evaluated by the Food & Drug Administration. These ingredients are not intended to diagnose, treat, cure or prevent any disease.
Headquartered in Purchase, NY and with offices in Tokyo and Shanghai, Maypro Group is a leading global supplier of specialty nutraceutical ingredients to the nutritional supplement, sports nutrition, pet and veterinary, cosmetic, functional food and fine chemical industries. In addition to being a leading supplier of mainstream products such as CoQ10, fish oil, glucosamine and various botanical extracts, Maypro also markets a very strong portfolio of clinically validated proprietary and branded ingredients, representing some of the top manufacturers from Japan, Europe, and the United States. For more information, please visit www.maypro.com. Click here for more information on L-92™.
For further information, please contact Jessica Szczechowicz at 914-251-0701 or [email protected]
